SPAK inhibitor ZT-1a demonstrates efficacy in experimental VCID
Feb. 9, 2024
The main causes of vascular cognitive impairment and dementia (VCID) are the breakdown of the blood-brain barrier, reactive astrogliosis and loss of myelination, but its molecular and cellular mechanisms are not clear enough.